What we do Sigachi Industries Ltd manufactures and distributes Micro Crystalline Cellulose (MCC) for pharma, nutraceutical, and food industries through advanced facilities in India and subsidiaries abroad. |
Founded in 1,989 |
Market share One of India’s largest MCC producers with significant global presence serving 65+ countries and 500+ customers. |
Problem solved Provides high-quality excipients and ingredients for pharmaceutical and nutrition sectors to enhance drug formulation and food product quality. |
Top clients or who we serve Serves pharmaceutical, nutraceutical, and food industries globally; including B2B customers and formulation companies. |
Key management Amit Raj Sinha (Managing Director & CEO), Rabindra Prasad Sinha (Whole-Time Director & Chairman), Chidambarnathan Shanmuganathan (Whole-Time Director). |
Our journey and innovations Evolved since 1989 from chemical producer to a leading MCC manufacturer, expanded into APIs and coatings, and formed international subsidiaries and JVs. |
Where we operate Primarily India with manufacturing bases in Telangana, Gujarat, Karnataka; subsidiaries and JV in USA, UAE, Saudi Arabia; exports worldwide. |
Top products or what we offer Micro Crystalline Cellulose Powder (59 grades), pharma excipients, APIs, pharmaceutical coatings like PureCoat and UltraMod, nutraceutical and food ingredients. |
Top brands PureCoat (pharma coating), UltraMod (pharma coating), Sigachi MCC (market leader in excipients), Trimax Bio Sciences API products. |
Raw materials needed Cellulose raw materials for MCC production and chemical inputs for APIs and coatings. |
Raw materials supplier Suppliers of cellulose fibers and chemicals from local and global vendors, details not specified. |
Recurring vs cyclical contribution Revenue mainly recurring from long-term customer contracts in pharma and nutrition sectors. |
Our industry position Industry leader in MCC with growing footprint in APIs and coatings; recognized for quality and compliance. |
Financial highlights FY25 consolidated revenue approx. Rs. 508.8 crores with net profit around Rs. 69.6 crores; steady CAGR with expanding margins. |
Geographical revenue split Approximately 72% revenue from outside India and 28% from Indian market. |
Order book - |
Whats driving growth Strong demand for pharmaceutical excipients, expansion in API segment, new coatings launch, capacity expansion, and global partnerships. |
Our future plans Expand MCC capacity, grow API business, deepen global footprints via subsidiaries and JV in Middle East and USA, focus on innovation. |
Our green promise Committed to sustainable waste management, energy conservation, and CSR benefiting over 12,600 lives. |
Our people and values Over 1800 employees globally, recognized as a great workplace emphasizing diversity, inclusion, and employee wellbeing. |
Key challenges ahead Mitigating operational risks post plant fire, navigating regulatory changes, managing supply chain and currency fluctuation risks. |
Interesting facts First in India for GAIN certification; largest MCC capacity in India; multiple accreditations including WHO-GMP and USFDA. |
Risks and strategy Risk management framework addresses financial, compliance, operational and reputational risks with regular senior management reviews and mitigation plans. |
